$DORM
Dorman Products, Inc.

2017 Q2 Form 10-Q Financial Statement

#000119312517158119 Filed on May 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q1
Revenue $221.6M $208.1M
YoY Change 5.75% 10.44%
Cost Of Revenue $132.9M $127.6M
YoY Change 4.3% 10.36%
Gross Profit $88.74M $80.59M
YoY Change 8.01% 10.56%
Gross Profit Margin 40.04% 38.72%
Selling, General & Admin $43.70M $41.66M
YoY Change 6.13% 6.17%
% of Gross Profit 49.24% 51.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.000M $4.500M
YoY Change 6.38% 25.0%
% of Gross Profit 5.63% 5.58%
Operating Expenses $43.70M $41.66M
YoY Change 6.13% 6.17%
Operating Profit $45.04M $38.93M
YoY Change 9.89% 15.69%
Interest Expense $100.0K $57.00K
YoY Change 61.29% 9.62%
% of Operating Profit 0.22% 0.15%
Other Income/Expense, Net $64.00K
YoY Change
Pretax Income $45.11M $38.87M
YoY Change 10.21% 15.7%
Income Tax $15.92M $14.20M
% Of Pretax Income 35.29% 36.54%
Net Earnings $29.19M $24.67M
YoY Change 12.34% 15.61%
Net Earnings / Revenue 13.17% 11.85%
Basic Earnings Per Share $0.85 $0.71
Diluted Earnings Per Share $0.85 $0.71
COMMON SHARES
Basic Shares Outstanding 34.39M shares 34.68M shares
Diluted Shares Outstanding 34.48M shares 34.73M shares

Balance Sheet

Concept 2017 Q2 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.3M $87.00M
YoY Change 77.82% 34.67%
Cash & Equivalents $156.3M $86.98M
Short-Term Investments
Other Short-Term Assets $3.000M $2.700M
YoY Change -44.44% -90.32%
Inventory $171.8M $187.6M
Prepaid Expenses
Receivables $232.9M $207.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $564.0M $484.7M
YoY Change 15.32% 1.68%
LONG-TERM ASSETS
Property, Plant & Equipment $88.84M $88.43M
YoY Change 0.46% 4.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $39.72M $20.23M
YoY Change 80.77% 43.78%
Total Long-Term Assets $174.6M $146.5M
YoY Change 18.07% 14.03%
TOTAL ASSETS
Total Short-Term Assets $564.0M $484.7M
Total Long-Term Assets $174.6M $146.5M
Total Assets $738.6M $631.2M
YoY Change 15.95% 4.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $71.65M $52.26M
YoY Change 35.49% -13.59%
Accrued Expenses $33.51M $36.60M
YoY Change 78.87% 16.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $110.4M $92.49M
YoY Change 40.34% -3.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.173M $5.572M
YoY Change 42.78% 24.88%
Total Long-Term Liabilities $8.173M $5.572M
YoY Change 42.78% 24.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $110.4M $92.49M
Total Long-Term Liabilities $8.173M $5.572M
Total Liabilities $118.6M $98.06M
YoY Change 40.51% -2.46%
SHAREHOLDERS EQUITY
Retained Earnings $575.5M $490.0M
YoY Change 13.04% 11.79%
Common Stock $44.53M $43.19M
YoY Change 2.43% -2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $620.0M $533.2M
YoY Change
Total Liabilities & Shareholders Equity $738.6M $631.2M
YoY Change 15.95% 4.3%

Cashflow Statement

Concept 2017 Q2 2016 Q1
OPERATING ACTIVITIES
Net Income $29.19M $24.67M
YoY Change 12.34% 15.61%
Depreciation, Depletion And Amortization $5.000M $4.500M
YoY Change 6.38% 25.0%
Cash From Operating Activities $38.10M $23.90M
YoY Change 202.38% 0.42%
INVESTING ACTIVITIES
Capital Expenditures $5.618M $5.598M
YoY Change -224.84% -2.63%
Acquisitions
YoY Change
Other Investing Activities -$13.10M
YoY Change
Cash From Investing Activities -$18.70M -$5.600M
YoY Change 315.56% -1.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.20M -10.00M
YoY Change 69.44% 809.09%
NET CHANGE
Cash From Operating Activities 38.10M 23.90M
Cash From Investing Activities -18.70M -5.600M
Cash From Financing Activities -12.20M -10.00M
Net Change In Cash 7.200M 8.300M
YoY Change 700.0% -51.18%
FREE CASH FLOW
Cash From Operating Activities $38.10M $23.90M
Capital Expenditures $5.618M $5.598M
Free Cash Flow $32.48M $18.30M
YoY Change 89.95% 1.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78659000
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34297170 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86978000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5291000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34449497 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34449497 shares
CY2017Q2 us-gaap Assets
Assets
738601000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
564002000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44181000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156344000
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13615000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
232924000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
344000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
71653000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33505000
CY2017Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
32432000
CY2017Q2 us-gaap Inventory Net
InventoryNet
171762000
CY2017Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
67059000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
738601000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8173000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
110449000
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
101941000
CY2017Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2762000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39716000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3117895
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88836000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
619979000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.11
CY2017Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
27.40
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
19671 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
164461 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
58.21
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4100000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
575454000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1406394 shares
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2972000
CY2017Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
200000
CY2017Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2800000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1076542
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
124592 shares
CY2017Q2 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
370600000
CY2017Q2 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
101250000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11899000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34517633 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34517633 shares
CY2016Q4 us-gaap Assets
Assets
711792000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
551614000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44187000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149121000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12429000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230526000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
345000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
72629000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19320000
CY2016Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
29788000
CY2016Q4 us-gaap Inventory Net
InventoryNet
168851000
CY2016Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
72833000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
711792000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6302000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103848000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
93223000
CY2016Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
2795000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29525000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88436000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
601642000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.52
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
145363 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
49.22
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
557110000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3116000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101084 shares
CY2016Q4 dorm Receivables Not Sold Additional Receivables Outstanding
ReceivablesNotSoldAdditionalReceivablesOutstanding
338300000
CY2016Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
99995000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2016 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
38970 shares
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2200000
CY2016 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
56.66
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73000 shares
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8319000
CY2016Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4499000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
127554000
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-442000
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
208148000
CY2016Q1 us-gaap Interest Paid
InterestPaid
70000
CY2016Q1 us-gaap Gross Profit
GrossProfit
80594000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11930000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
24671000
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
996000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38874000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5598000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4468000
CY2016Q1 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
2500000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
405000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6139000
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1487000
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
56000 shares
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38931000
CY2016Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-57000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-9997000
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2568000
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5901000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14203000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23914000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5598000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34734000 shares
CY2016Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
135200000
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41663000
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34678000 shares
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0.0
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
440000
CY2016Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
400000
CY2016Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
9986000
CY2016Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-11000
CY2017Q2 dei Entity Registrant Name
EntityRegistrantName
Dorman Products, Inc.
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37464 shares
CY2017Q2 dei Document Type
DocumentType
10-Q
CY2017Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000868780
CY2017Q2 dei Document Period End Date
DocumentPeriodEndDate
2017-04-01
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7223000
CY2017Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5005000
CY2017Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q2 dei Amendment Flag
AmendmentFlag
false
CY2017Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.85
CY2017Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.85
CY2017Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
132882000
CY2017Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1186000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
221625000
CY2017Q2 us-gaap Interest Paid
InterestPaid
61000
CY2017Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13127000
CY2017Q2 us-gaap Gross Profit
GrossProfit
88743000
CY2017Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-668000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
29187000
CY2017Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
75000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
45106000
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18745000
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2473000
CY2017Q2 us-gaap Gain Loss On Sale Of Accounts Receivable
GainLossOnSaleOfAccountsReceivable
2500000
CY2017Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-144000
CY2017Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
818000
CY2017Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
191000
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
94000 shares
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
45042000
CY2017Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
8417000
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
64000
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-12177000
CY2017Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1046000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15919000
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
38145000
CY2017Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5618000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
52.19
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
78.21
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
32000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34479000 shares
CY2017Q2 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
146000000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43701000
CY2017Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3830 shares
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2017Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
300000
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.90
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34385000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
78.40
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
37637 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
276 shares
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
53.86
CY2017Q2 dei Trading Symbol
TradingSymbol
DORM
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
57011 shares
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
653000
CY2017Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
600000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
55508 shares
CY2017Q2 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
11321000
CY2017Q2 dorm Stock Repurchased And Retired During Period Average Purchase Price
StockRepurchasedAndRetiredDuringPeriodAveragePurchasePrice
75.45
CY2017Q2 dorm Maximum Grant Period From Date Of Plan Approval
MaximumGrantPeriodFromDateOfPlanApproval
P10Y
CY2017Q2 dorm Date Of Plan Approval
DateOfPlanApproval
2009-05-20
CY2017Q2 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-856000

Files In Submission

Name View Source Status
0001193125-17-158119-index-headers.html Edgar Link pending
0001193125-17-158119-index.html Edgar Link pending
0001193125-17-158119.txt Edgar Link pending
0001193125-17-158119-xbrl.zip Edgar Link pending
d368068d10q.htm Edgar Link pending
d368068dex311.htm Edgar Link pending
d368068dex312.htm Edgar Link pending
d368068dex32.htm Edgar Link pending
dorm-20170401.xml Edgar Link completed
dorm-20170401.xsd Edgar Link pending
dorm-20170401_cal.xml Edgar Link unprocessable
dorm-20170401_def.xml Edgar Link unprocessable
dorm-20170401_lab.xml Edgar Link unprocessable
dorm-20170401_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending